Our results substantiate this hypothesis by demonstrating that Dityr induces glucose metabolism disorders through thyroid hormone signaling disruption and systemic oxidative stress/inflammation, ultimately leading to pancreatic β-cell dysfunction, impaired insulin secretion, and hyperglycemia in mice. This evidence concerns the gene INS and glucose metabolism disease.